These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7993816)

  • 1. Detection of fetal RhD sequence from peripheral blood of sensitized RhD-negative pregnant women.
    Lo YM; Noakes L; Bowell PJ; Fleming KA; Wainscoat JS
    Br J Haematol; 1994 Jul; 87(3):658-60. PubMed ID: 7993816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Examination of the RHD gene by non-invasive method in plasma of alloimmunized mother allowed to abandon invasive procedures and to deliver a healthy child].
    Orzińska A; Guz K; Brojer E; Zupańska B
    Ginekol Pol; 2004 Dec; 75(12):963-5. PubMed ID: 15751219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-invasive fetal RhD typing and RhD negative pregnant women--preliminary observations].
    Guz K; Brojer E; Zupańska B; Orzińska A; Kalińska A; Bec JR
    Ginekol Pol; 2004 Jan; 75(1):21-5. PubMed ID: 15112469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
    de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
    BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal Rhesus D genotyping on amniocytes in alloimmunised pregnancies using fluorescence duplex polymerase chain reaction.
    Crombach G; Picard F; Beckmann M; Tutschek B; Bald R; Niederacher D
    Br J Obstet Gynaecol; 1997 Jan; 104(1):15-9. PubMed ID: 8988689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
    Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
    Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.
    Finning K; Martin P; Summers J; Massey E; Poole G; Daniels G
    BMJ; 2008 Apr; 336(7648):816-8. PubMed ID: 18390496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers.
    Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Elliott P; Pratt G; Littlewood TJ; Fleming KA
    Ann N Y Acad Sci; 1994 Sep; 731():229-36. PubMed ID: 7944125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.
    Runkel B; Bein G; Sieben W; Sow D; Polus S; Fleer D
    BMC Pregnancy Childbirth; 2020 Feb; 20(1):83. PubMed ID: 32033599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
    Clausen FB; Barrett AN;
    Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA.
    Gönenç G; Işçi H; Yiğiter AB; Hançer V; Büyükdoğan M; Güdücü N; Dünder I
    Clin Exp Obstet Gynecol; 2015; 42(3):344-6. PubMed ID: 26152007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and benefits of non-invasive fetal RhD determination.
    Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma.
    Finning K; Martin P; Daniels G
    Ann N Y Acad Sci; 2004 Jun; 1022():119-23. PubMed ID: 15251949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of polymerase chain reaction to determine fetal RhD status.
    Rossiter JP; Blakemore KJ; Kickler TS; Kasch LM; Khouzami AN; Pressman EK; Sciscione AC; Kazazian HH
    Am J Obstet Gynecol; 1994 Oct; 171(4):1047-51. PubMed ID: 7943068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of rhesus isoimmunization by preimplantation genetic diagnosis.
    Avner R; Reubinoff BE; Simon A; Zentner BS; Friedmann A; Mitrani-Rosenbaum S; Laufer N
    Mol Hum Reprod; 1996 Jan; 2(1):60-2. PubMed ID: 9238659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping.
    Stensrud M; Bævre MS; Alm IM; Wong HY; Herud I; Jacobsen B; de Vos DDJA; Stjern HE; Sørvoll IH; Barane JB; Bagås TE; Rasmussen M; Ulvahaug N; Wamstad V; Tomter G; Akkök CA
    Fetal Diagn Ther; 2023; 50(4):276-281. PubMed ID: 37379821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.